An open-label investigator-led study being conducted in pediatric subjects Netherton Syndrome
Latest Information Update: 02 Feb 2025
Price :
$35 *
At a glance
- Drugs QRX 003 (Primary)
- Indications Netherton Syndrome
- Focus Therapeutic Use
- 02 Feb 2025 New trial record